lopirin 50mg squibb tablette
bristol-myers squibb gmbh & co. kgaa - captopril - tablette - captopril 50.mg
lopirin 25mg squibb tablette
bristol-myers squibb gmbh & co. kgaa - captopril - tablette - captopril 25.mg
meta-iodobenzylguanidin-iod-123 bristol-myers squibb injektionslösung
bristol-myers squibb pharma belgium sprl - iobenguan ((123)i) - injektionslösung - iobenguan ((123)i) 0.6-2.3ng
naltrexon bristol-myers squibb filmtablette
bristol-myers squibb gmbh & co. kgaa - naltrexonhydrochlorid - filmtablette - naltrexonhydrochlorid 50.mg
para-iodophenylpentadekansäure-iod-123 bristol-myers squibb injektionslösung
bristol-myers squibb pharma belgium sprl - injektionslösung
thallous (tl-201) chloride injection, bristol-myers squibb injektionslösung
bristol-myers squibb pharma belgium sprl - ((201)tl)thallium(i)-chlorid - injektionslösung - ((201)tl)thallium(i)-chlorid 37.mbq
fludrocortison
bristol-myers squibb gmbh & co. kgaa (8004345) - fludrocortisonacetat (ph.eur.) - tablette - teil 1 - tablette; fludrocortisonacetat (ph.eur.) (03511) 0,1 milligramm
opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanom - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
sotyktu
bristol-myers squibb pharma eeig - deucravacitinib - psoriasis - immunsuppressiva - treatment of moderate-to-severe plaque psoriasis in adults.
capozide mite
bristol-myers squibb gmbh & co. kgaa (8004345) - hydrochlorothiazid; captopril - tablette - teil 1 - tablette; hydrochlorothiazid (00512) 12,5 milligramm; captopril (19545) 25 milligramm